1. Home
  2. IMRX vs MAGN Comparison

IMRX vs MAGN Comparison

Compare IMRX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.84

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$10.39

Market Cap

316.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRX
MAGN
Founded
2008
1864
Country
United States
United States
Employees
N/A
8500
Industry
Biotechnology: Pharmaceutical Preparations
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
340.7M
316.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IMRX
MAGN
Price
$5.84
$10.39
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$17.20
$12.00
AVG Volume (30 Days)
679.3K
386.9K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
37.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
$3.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$7.82
52 Week High
$10.08
$15.52

Technical Indicators

Market Signals
Indicator
IMRX
MAGN
Relative Strength Index (RSI) 60.07 49.14
Support Level $5.31 $8.82
Resistance Level $7.67 $12.09
Average True Range (ATR) 0.34 0.51
MACD 0.02 0.21
Stochastic Oscillator 93.53 59.77

Price Performance

Historical Comparison
IMRX
MAGN

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: